Prosthetic Heart Valves - Medical Devices Pipeline Assessment, 2018

  • ID: 4580451
  • Report
  • 437 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • Collagen Solutions Plc
  • HLT, Inc.
  • Mitralix Ltd.
  • Revivicor Inc
  • University of Arizona
  • MORE
Prosthetic Heart Valves - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Prosthetic Heart Valves - Medical Devices Pipeline Assessment, 2018" provides an overview of Prosthetic Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prosthetic Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Prosthetic Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Prosthetic Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Prosthetic Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • Collagen Solutions Plc
  • HLT, Inc.
  • Mitralix Ltd.
  • Revivicor Inc
  • University of Arizona
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Prosthetic Heart Valves Overview

3 Products under Development
3.1 Prosthetic Heart Valves - Pipeline Products by Stage of Development
3.2 Prosthetic Heart Valves - Pipeline Products by Segment
3.3 Prosthetic Heart Valves - Pipeline Products by Territory
3.4 Prosthetic Heart Valves - Pipeline Products by Regulatory Path
3.5 Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Prosthetic Heart Valves - Ongoing Clinical Trials

4 Prosthetic Heart Valves - Pipeline Products under Development by Companies
4.1 Prosthetic Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Prosthetic Heart Valves - Pipeline Products by Stage of Development

5 Prosthetic Heart Valves Companies and Product Overview
5.1 4C Medical Technologies Inc Company Overview
5.2 Abbott Vascular Inc Company Overview
5.3 Admedus Ltd Company Overview
5.4 Aegis Surgical Limited Company Overview
5.5 Annulon Company Overview
5.6 AorTech International Plc Company Overview
5.7 AorTx, Inc. Company Overview
5.8 Arbor Surgical Technologies, Inc. Company Overview
5.9 Boston Children's Hospital Company Overview
5.10 Boston Scientific Corp Company Overview
5.11 Carena Healthcare Ltd Company Overview
5.12 Cephea Valve Technologies, Inc. Company Overview
5.13 Children's Hospital Boston Company Overview
5.14 Clemson University Company Overview
5.15 Colibri Heart Valve, LLC Company Overview
5.16 Collagen Solutions Plc Company Overview
5.17 Colorado State University Company Overview
5.18 CorMatrix Cardiovascular Inc Company Overview
5.19 CryoLife Inc Company Overview
5.20 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.21 Daidalos Solutions BV Company Overview
5.22 Direct Flow Medical Inc (Inactive) Company Overview
5.23 DSM Dyneema BV Company Overview
5.24 Dura LLC Company Overview
5.25 Edwards Lifesciences Corp Company Overview
5.26 Emory University Company Overview
5.27 Endoluminal Technology Research, LLC Company Overview
5.28 Florida International University Company Overview
5.29 Georgia Institute of Technology Company Overview
5.30 Hancock Jaffe Laboratories Inc Company Overview
5.31 HighLife SAS Company Overview
5.32 HLT, Inc. Company Overview
5.33 Hocor Cardiovascular Technologies, LLC Company Overview
5.34 Innovia LLC Company Overview
5.35 JC Medical, Inc. Company Overview
5.36 JenaValve Technology GmbH Company Overview
5.37 Leman Cardiovascular SA Company Overview
5.38 LivaNova PLC Company Overview
5.39 Mayo Clinic Company Overview
5.40 Medi-Line S.A. Company Overview
5.41 Medtronic plc Company Overview
5.42 Meril Life Sciences Pvt Ltd Company Overview
5.43 Micro Interventional Devices, Inc. Company Overview
5.44 MicroPort Scientific Corp Company Overview
5.45 Mitralix Ltd. Company Overview
5.46 MitrAssist Ltd. Company Overview
5.47 Mitricares Company Overview
5.48 MValve Technologies Ltd. Company Overview
5.49 NaviGate Cardiac Structures, Inc. Company Overview
5.50 Neovasc Inc Company Overview
5.51 Peca Labs, Inc. Company Overview
5.52 PolyNova Cardiovascular LLC (Inactive) Company Overview
5.53 Polyvascular Corp Company Overview
5.54 Rambam Health Care Campus Company Overview
5.55 RegenaGraft Company Overview
5.56 ReValve Med Inc Company Overview
5.57 Revivicor Inc Company Overview
5.58 SAS Cormove Company Overview
5.59 Sino Medical Sciences Technology Inc Company Overview
5.60 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.61 St. Jude Medical LLC Company Overview
5.62 Stellenbosch University Company Overview
5.63 Strait Access Technologies (Pty) Ltd Company Overview
5.64 Symetis SA Company Overview
5.65 Thoratec Corp Company Overview
5.66 Thubrikar Aortic Valve, Inc. Company Overview
5.67 Tissue Regenix Ltd Company Overview
5.68 Trinity College Dublin Company Overview
5.69 TTK Healthcare Ltd Company Overview
5.70 University College London Company Overview
5.71 University of Arizona Company Overview
5.72 University of California Company Overview
5.73 University of California Irvine Company Overview
5.74 University of California San Francisco Company Overview
5.75 University of Cambridge Company Overview
5.76 University of Colorado Company Overview
5.77 University of Florida Company Overview
5.78 University of Iowa Company Overview
5.79 University of Minnesota Company Overview
5.80 University of Pennsylvania Company Overview
5.81 University of South Florida Company Overview
5.82 University of Zurich Company Overview
5.83 Valtech Cardio Ltd Company Overview
5.84 ValveXchange, Inc. (Inactive) Company Overview
5.85 Vascular Concepts Ltd Company Overview
5.86 Venus MedTech Company Overview
5.87 VueKlar Cardiovascular Ltd (Inactive) Company Overview
5.88 Xeltis AG Company Overview

6 Prosthetic Heart Valves- Recent Developments
6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.2 May 31, 2018: JC Medical Announces First-in-Human Treatment with the Unique Transfemoral J-Valve TAVI Device for Aortic Regurgitation
6.3 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.4 May 23, 2018: Abbott's Investigational Tendyne Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
6.5 May 22, 2018: Treatment with Abbott s Portico Transcatheter Aortic Valve Showed Portico is Safe and Reduces Severe Aortic Stenosis at 30 Days in Real-World Setting
6.6 May 22, 2018: Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve
6.7 May 22, 2018: Admedus: TAVR Progress Continues With Filing of New Provisional Patents
6.8 May 21, 2018: Edwards Announces Key Events For EuroPCR 2018
6.9 May 21, 2018: NaviGate Cardiac Structures reports “excellent valvular function” at 1-year follow-up of first patient to receive GATE tricuspid valved stent via transjugular access
6.10 May 17, 2018: MicroPort CardioFlow Releases One-year Clinical Outcome of VitaFlow
6.11 May 17, 2018: MicroPort CardioFlow Attends Fourth China Valve (Hangzhou) Meeting
6.12 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
6.13 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
6.14 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
6.15 May 10, 2018: Neovasc Announces Results for the First Quarter 2018
6.16 May 09, 2018: Computer-Designed Customized Regenerative Heart Valves
6.17 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.18 May 04, 2018: Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
6.19 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Prosthetic Heart Valves - Pipeline Products by Stage of Development
Table 2: Prosthetic Heart Valves - Pipeline Products by Segment
Table 3: Prosthetic Heart Valves - Pipeline Products by Territory
Table 4: Prosthetic Heart Valves - Pipeline Products by Regulatory Path
Table 5: Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
Table 6: Prosthetic Heart Valves - Ongoing Clinical Trials
Table 7: Prosthetic Heart Valves Companies - Pipeline Products by Stage of Development
Table 8: Prosthetic Heart Valves - Pipeline Products by Stage of Development
Table 9: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: AltaValve - Product Status
Table 11: AltaValve - Product Description
Table 12: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Table 15: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 16: Tendyne Bioprosthetic Mitral Valve Implantation System - Expanded Clinical Study of the Tendyne Mitral Valve System
Table 17: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Transcatheter Aortic Valve Replacement Device - Product Status
Table 19: Transcatheter Aortic Valve Replacement Device - Product Description
Table 20: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 21: pTAo-TAVR - Product Status
Table 22: pTAo-TAVR - Product Description
Table 23: Annulon Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Mitral Valve Replacement Device - Product Status
Table 25: Mitral Valve Replacement Device - Product Description
Table 26: AorTech International Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: AorTech Polymer Valve - Product Status
Table 28: AorTech Polymer Valve - Product Description
Table 29: AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 30: AorTx Valve - Product Status
Table 31: AorTx Valve - Product Description
Table 32: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Trilogy Aortic Valve System - Product Status
Table 34: Trilogy Aortic Valve System - Product Description
Table 35: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Pulmonary Valve Replacement Device - Product Status
Table 37: Pulmonary Valve Replacement Device - Product Description
Table 38: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 39: ACURATE TAVR - Product Status
Table 40: ACURATE TAVR - Product Description
Table 41: Gen 4 Lotus Valve System - Product Status
Table 42: Gen 4 Lotus Valve System - Product Description
Table 43: Lotus Edge Sheath 15F - Product Status
Table 44: Lotus Edge Sheath 15F - Product Description
Table 45: Lotus Edge Valve System - 21 mm - Product Status
Table 46: Lotus Edge Valve System - 21 mm - Product Description
Table 47: Lotus Edge Valve System - 23 mm - Product Status
Table 48: Lotus Edge Valve System - 23 mm - Product Description
Table 49: Lotus Edge Valve System - 25 mm - Product Status
Table 50: Lotus Edge Valve System - 25 mm - Product Description
Table 51: Lotus Edge Valve System - 27 mm - Product Status
Table 52: Lotus Edge Valve System - 27 mm - Product Description
Table 53: Lotus Edge Valve System - 29 mm - Product Status
Table 54: Lotus Edge Valve System - 29 mm - Product Description
Table 55: Lotus Valve System - 21 mm - Product Status
Table 56: Lotus Valve System - 21 mm - Product Description
Table 57: Lotus Valve System - 23 mm - Product Status
Table 58: Lotus Valve System - 23 mm - Product Description
Table 59: Lotus Valve System - 25 mm - Product Status
Table 60: Lotus Valve System - 25 mm - Product Description
Table 61: Lotus Valve System - 27 mm - Product Status
Table 62: Lotus Valve System - 27 mm - Product Description
Table 63: Lotus Valve System - 29 mm - Product Status
Table 64: Lotus Valve System - 29 mm - Product Description
Table 65: Transaortic Sheath - Product Status
Table 66: Transaortic Sheath - Product Description
Table 67: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 68: Lotus Valve System - 23 mm - Experience with Percutaneous Transcatheter Aortic Valve Implantation in Patients with Symptomatic Aortic Valve Disease in Two German Centers
Table 69: Lotus Valve System - 23 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 70: Lotus Valve System - 23 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 71: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 72: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 73: Lotus Valve System - 23 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 74: Lotus Valve System - 27 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 75: Lotus Valve System - 27 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 76: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 77: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 78: Lotus Valve System - 27 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 79: Lotus Valve System - 25 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 80: Lotus Valve System - 25 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 81: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 82: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 83: Lotus Valve System - 25 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 84: Lotus Valve System - 21 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 85: Lotus Valve System - 21 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 86: Lotus Valve System - 21 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 87: Lotus Valve System - 29 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 88: Lotus Valve System - 29 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND

List of Figures
Figure 1: Prosthetic Heart Valves - Pipeline Products by Stage of Development
Figure 2: Prosthetic Heart Valves - Pipeline Products by Segment
Figure 3: Prosthetic Heart Valves - Pipeline Products by Territory
Figure 4: Prosthetic Heart Valves - Pipeline Products by Regulatory Path
Figure 5: Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
Figure 6: Prosthetic Heart Valves - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 4C Medical Technologies Inc
  • Abbott Vascular Inc
  • Admedus Ltd
  • Aegis Surgical Limited
  • Annulon
  • AorTech International Plc
  • AorTx, Inc.
  • Arbor Surgical Technologies, Inc.
  • Boston Children's Hospital
  • Boston Scientific Corp
  • Carena Healthcare Ltd
  • Cephea Valve Technologies, Inc.
  • Children's Hospital Boston
  • Clemson University
  • Colibri Heart Valve, LLC
  • Collagen Solutions Plc
  • Colorado State University
  • CorMatrix Cardiovascular Inc
  • CryoLife Inc
  • Cytograft Tissue Engineering Inc
  • Daidalos Solutions BV
  • Direct Flow Medical Inc
  • DSM Dyneema BV
  • Dura LLC
  • Edwards Lifesciences Corp
  • Emory University
  • Endoluminal Technology Research, LLC
  • Florida International University
  • Georgia Institute of Technology
  • Hancock Jaffe Laboratories Inc
  • HighLife SAS
  • HLT, Inc.
  • Hocor Cardiovascular Technologies, LLC
  • Innovia LLC
  • JC Medical, Inc.
  • JenaValve Technology GmbH
  • Leman Cardiovascular SA
  • LivaNova PLC
  • Mayo Clinic
  • Medi-Line S.A.
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corp
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • Mitricares
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc
  • Peca Labs, Inc.
  • PolyNova Cardiovascular LLC
  • Polyvascular Corp
  • Rambam Health Care Campus
  • RegenaGraft
  • ReValve Med Inc
  • Revivicor Inc
  • SAS Cormove
  • Sino Medical Sciences Technology Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical LLC
  • Stellenbosch University
  • Strait Access Technologies (Pty) Ltd
  • Symetis SA
  • Thoratec Corp
  • Thubrikar Aortic Valve, Inc.
  • Tissue Regenix Ltd
  • Trinity College Dublin
  • TTK Healthcare Ltd
  • University College London
  • University of Arizona
  • University of California
  • University of California Irvine
  • University of California San Francisco
  • University of Cambridge
  • University of Colorado
  • University of Florida
  • University of Iowa
  • University of Minnesota
  • University of Pennsylvania
  • University of South Florida
  • University of Zurich
  • Valtech Cardio Ltd
  • ValveXchange, Inc.
  • Vascular Concepts Ltd
  • Venus MedTech
  • VueKlar Cardiovascular Ltd
  • Xeltis AG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll